Morning Tea

SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Lupin has reportedly hiked price of its generic diabetes drug Fortamet by three times for 500 mg and 1000 mg variants. Despite the price hike,
the company's drug is still 15% cheaper than its innovator. Fortamet has two generic players in the market, Lupin and Mylan. Lupin has 60%
market share of the drug in value terms. Mylan, which got the approval for the drug in 2013, has not yet launched its generic version.
Fortamet's current market size is estimated at $170 million. Lupin is an innovation led transnational pharmaceutical company producing and
developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.
Technical Outlook : The stock has given breakout of horizontal channel formation at 1975.10 levels on daily chart with above average volume.
Moreover, prices are trading above 60 DEMA, which indicate short to medium term trend is up. The momentum indictor RSI has moved above
60 levels, which suggest positive breath in the stock. So for trading perspective, one could Buy in the range of 1978-1990 for the Target of 2040
with the SL of 1955
Hindustan Construction Company (HCC) has bagged order worth Rs 1783.12 crore from National Highways Authority of India (NHAI) for
constructing a 36 Km highway which includes 3 krns of tunnels between Ramban and Banihaf in Jammu & Kashmir. The project is a part of
NHDP Phase-II program of NHAI on NH1A (now NH44) and is known for its difficult terrain and low temperatures especially in winter seasons.
The NH1A is major road connectivity to Srinagar from rest of the country and this project will decongest the existing narrow road between
Ramban and Banihal and will cut short travel time considerably due to provision of tunnels. HCC is a leader in engineering and construction
space. The company has established a vast presence and gained recognition in the sectors of Hydro Power, Water Solutions, Transportation and
Nuclear Power.
Technical Outlook: On daily chart, prices have been trading in falling channel formation since last one and half year. Recently, price has taken
support of lower band of channel formation at 16.20 levels. Furthermore, stock is trading above 21 DEMA, which indicates short term trend is up.
The momentum indictor RSI has moved above 40 levels on daily chart, which shows positive breath in the stock. So for trading perspective, one
couldBuyintherangeof17.85-18.20 fortheTargetof20.20 withtheSLof17
LUPIN
HCC
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
28th Sept 2015
Buy in the range of 17.85-18.20 for the Target of 20.20 with the SL of 17
Buy in the range of 1978-1990 for the Target of 2040 with the SL of 1955
Global cues are mixed as the US markets closed mixed on Friday. On Friday, the S&P 500 erased an early Federal Reserve-driven rally and closed
slightly lower amid a selloff in biotech shares, and the Nasdaq lost 1 percent. The Dow, however, managed to rise 0.7 percent. Fed Chair Janet
Yellen last Thursday revived prospects of an interest rate hike before year-end, easing concerns about slowing global growth that helped the
dollar and risk assets, which have been buffeted by fears over China's sputtering economy. Strong second quarter U.S. GDP data released on
Friday further sharpened the case for the Fed to raise rates in 2015. Focus now turns to this Friday's all-important U.S. non-farm payrolls as the
markets try to gauge whether labour market conditions are strong enough for the Fed to tighten monetary policy. The Dow Jones industrial
average rose 113 points, or 0.70 percent, to 16,314.67, the S&P 500 lost -0.90 points, or -0.05percent, to 1,931.34 and the Nasdaq Composite
dropped -47.98 points, or -1.01 percent, to 4,686.50
Asian equity markets were mixed on Monday as investors digested key data from the world's second-biggest economy. But volumes in the
region were light with Hong Kong, Taiwan and South Korea shut for the Mid-Autumn Festival. Chinese industrial profits declined 8.8 percent on
year in August, worse than July's 2.9 percent fall, the National Statistics Bureau announced at the market open. For the first eight months of the
year, profits slid 1.9 percent as forty-two straight months of tanking producer prices erodes earnings growth. The main economic reports
investors are anticipating this week are China's official September PMI and the final Caixin/Markit PMI, both due on Thursday. The data will be
closely watched after Caixin's preliminary reading for September touched a six-and-a-half-year low of 47, well below the key 50-level. The
Shanghai Composite index traded at -0.95% to 3063.15, Hang Seng index traded at 0.43 % to 21186.32, Japan's benchmark Nikkei 225 index
traded at -1.15% to 17677.12, South Korea's Kospi index down by -0.22 % to 1942.85 levels. The SGX Nifty suggests a negative opening for our
markets as it is trading at 7881, down by 43 points.

Bulk Deal
Corporate Action / Result Calendar
Morning Tea
28th Sept 2015
Security in Ban
Corporate Action:
Sr.No Deal Date Security Code Security Name Client Name Deal Type Quantity Price
1 24/09/2015 533150 GODREJPROP GODREJ INDUSTRIES LTD S 2,510,000 314.85
2 24/09/2015 533150 GODREJPROP GODREJ INVESTMENTS LIMITED B 1,255,000 314.85
3 24/09/2015 533150 GODREJPROP GODREJ N BOYCE MFG CO LTD B 1,255,000 314.85
4 24/09/2015 538715 DHABRIYA HEM SEC LTD S 120,000 47.63
5 24/09/2015 538715 DHABRIYA SANTOSH BHANSALI B 112,000 47.64
6 24/09/2015 531146 MEDICAMEQ RAJASTHAN GLOBAL SECURITIES LTD B 102,667 35.58
7 24/09/2015 539331 VETO CLASSIC SHARETRADING PRIVATE LIMITED S 101,000 80.91
8 24/09/2015 538713 ATISHAY HEM SEC LTD S 88,000 52.93
9 24/09/2015 538713 ATISHAY SANTOSH BHANSALI HUF B 88,000 52.93
10 24/09/2015 524830 ELDERHCL M.PRASAD & CO LTD B 47,000 28.80

Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Ritesh Patel Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
28th Sept 2015
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking
Pvt Ltd., ou=Research Dept.,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2015.09.28 08:26:04 +05'30'

Morning Tea

More Related Content

What's hot

Viewers also liked

Similar to Morning Tea

Recently uploaded

Morning Tea